Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status
Authors:
- Aanchal GuptaAGAanchal Gupta
- Venkatesh C. PrabhakaranVPVenkatesh C. Prabhakaran
- 22 October 2012
- journal article
- Published by Taylor & Francis in Orbit
- Vol. 31 (6) , 386-389
Abstract
Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuclear antigen (PCNA), Bcl-2, estrogen and progesterone receptors (ER & PR), CD31, D2-40, and VEGF were investigated in 11 specimens. Results: Immunohistochemical staining revealed positivity for PCNA in ten of the 11 cases (91%). Bcl-2 was positive in 8 cases (73%). VEGF and PR were each weakly positive in 3 cases. All cases were negative for Mib-1, ER and D2-40. The staining was localized around the endothelium. Conclusion: This is the first study to characterise in detail the immunohistochemical features of orbital CHs. The proliferative markers PCNA and Mib-1 show discordant expression in these lesions and the expression of PCNA and Bcl-2 in the absence of Mib-1 is indicative of low proliferative potential. Small subsets of these tumors express PR and VEGF, which may partly explain the proliferative capacity of some orbital CHs.Keywords
This publication has 14 references indexed in Scilit:
- Growth Potential of Orbital Cavernous Hemangioma Suggested by Vascular Endothelial Growth Factor and its Receptor Flk-1Neurologia medico-chirurgica, 2007
- Recurrent Multiple Cavernous Hemangiomas of the Orbit in Association With Systemic TumorsAmerican Journal of Ophthalmology, 2006
- Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer CellsCancer Research, 2004
- Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of AngiosarcomasLaboratory Investigation, 2002
- Progesterone receptor expression in orbital cavernous hemangiomasVirchows Archiv, 2000
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: An immunocytochemical study of 42 casesSurgical Neurology, 1997
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990
- Cavernous hemangioma of the orbitJournal of Neurosurgery, 1979
- Cavernous Hemangioma of the OrbitArchives of Ophthalmology (1950), 1970